Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States.

Liu SV, Dasgupta A, Latremouille-Viau D, Rossi C, Rai P, Barlesi F, Leal TA

Open source

DOI
10.1200/go.24.00138
Published
2024 Sep
Container
JCO global oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/go.24.00138,
  title = {Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States.},
  author = {Liu SV and Dasgupta A and Latremouille-Viau D and Rossi C and Rai P and Barlesi F and Leal TA},
  year = {2024},
  journal = {JCO global oncology},
  doi = {10.1200/go.24.00138},
  url = {https://doi.org/10.1200/go.24.00138}
}

RIS

TY  - JOUR
TI  - Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States.
AU  - Liu SV
AU  - Dasgupta A
AU  - Latremouille-Viau D
AU  - Rossi C
AU  - Rai P
AU  - Barlesi F
AU  - Leal TA
PY  - 2024
JO  - JCO global oncology
DO  - 10.1200/go.24.00138
UR  - https://doi.org/10.1200/go.24.00138
ER  - 

APA

SV, L., A, D., D, L., C, R., P, R., F, B., & TA, L. (2024). Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States.. JCO global oncology. https://doi.org/10.1200/go.24.00138

Source records